Wang Carol, Roy Nikita, Montalmant Keisha E, Shamamian Peter, Seyidova Nargiz, Oleru Olachi, Graziano Francis, Jacobs Jordan M S, Sbitany Hani, Henderson Peter W
Division of Plastic and Reconstructive Surgery, Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, New York.
J Reconstr Microsurg. 2025 Sep;41(7):631-640. doi: 10.1055/a-2483-5472. Epub 2024 Nov 25.
Hybrid deep inferior epigastric perforator (DIEP) flap and simultaneous silicone implant breast reconstruction procedures ("DIEP + I") have many conceptual advantages compared with either reconstruction method alone, but the outcomes of DIEP + I reconstruction have not yet been well studied. Therefore, the purpose of this study was to compare the outcomes of DIEP + I with implant-only and DIEP-only reconstruction.A retrospective review was conducted of patients undergoing DIEP + I, implant-only, and DIEP-only breast reconstruction from 2019 to 2023 at a single institution. Demographics and complication rates were compared between groups.A total of 145 patients were included in the DIEP + I ( = 26), implant-only ( = 59), and DIEP-only ( = 60) groups. The DIEP + I group had a lower overall complication rate than implant-only reconstruction (18.4 vs. 41.1%, = 0.014), which was primarily due to the lower incidence of infections in the DIEP + I group (2.6 vs. 22.2%, = 0.006). Accordingly, DIEP + I reconstruction decreased the odds of infection by 90% (OR = 0.095, = 0.024) compared with implant-only reconstruction. The DIEP + I group had similar rates of wound healing and implant-related complications compared with the implant-only and DIEP-only groups, and no patients in the DIEP + I group experienced flap loss.DIEP + I breast reconstruction had a lower rate of infectious complications than implant-only reconstruction, and no higher rate of flap compromise or wound healing complications. This technique could be considered as a means of minimizing infection risk in patients with other risk factors who are seeking implant-based reconstruction, and of enhancing breast projection in patients who are seeking DIEP flap reconstruction.
腹壁下深动脉穿支(DIEP)皮瓣混合联合同期硅胶植入乳房重建手术(“DIEP + I”)与单独采用任何一种重建方法相比,具有诸多概念上的优势,但DIEP + I重建的效果尚未得到充分研究。因此,本研究的目的是比较DIEP + I与单纯植入物重建和单纯DIEP重建的效果。对2019年至2023年在单一机构接受DIEP + I、单纯植入物和单纯DIEP乳房重建的患者进行了回顾性研究。比较了各组的人口统计学数据和并发症发生率。DIEP + I组(n = 26)、单纯植入物组(n = 59)和单纯DIEP组(n = 60)共纳入145例患者。DIEP + I组的总体并发症发生率低于单纯植入物重建组(18.4%对41.1%,P = 0.014),这主要是由于DIEP + I组感染发生率较低(2.6%对22.2%,P = 0.006)。因此,与单纯植入物重建相比,DIEP + I重建使感染几率降低了90%(OR = 0.095,P = 0.024)。与单纯植入物组和单纯DIEP组相比,DIEP + I组的伤口愈合率和植入物相关并发症发生率相似,且DIEP + I组无患者出现皮瓣丢失。DIEP + I乳房重建的感染性并发症发生率低于单纯植入物重建,且皮瓣受损或伤口愈合并发症发生率没有更高。对于有其他风险因素且寻求植入物重建的患者,该技术可被视为降低感染风险的一种手段;对于寻求DIEP皮瓣重建的患者,该技术可增强乳房突出度。